期刊文献+

PGC在不同胃疾病黏膜中的表达及与血清学水平的关系 被引量:1

Comparison of gastric expression and serum levels of PGC in patients with various gastric diseases
下载PDF
导出
摘要 目的:检测不同胃疾病黏膜中胃蛋白酶原(pe-psinogen C,PGC)的表达及血清sPGC、sPGA浓度,分析二者的相关性,给临床工作提供更有益信息.方法:免疫组织化学染色法检测不同胃疾病黏膜组织中PGC的表达,并结合ELISA法检测血清中sPGC、sPGA的含量.之后用SPSS16.0分析软件进行统计学处理,P<0.05具有统计学意义.结果:PGC在不同胃疾病黏膜中的表达有差异(P=0.000).浅表-萎缩-伴肠化-伴异型增生-腺癌,PGC阳性率呈现递减.sPGC、sPGA浓度在各组间比较差异有统计学意义(P=0.000,P=0.000).sPGA呈现递减,浅表组与其余各组相比差异有统计学意义(P=0.035,0.000,0.000,0.000);萎缩组与其余各组相比差异有统计学意义(P=0.000,0.000,0.031);肠化组/异型增生组与胃癌组比较差异有统计学意义(P=0.047,0.034);sPGC表现为逐渐上降趋势,胃癌组与其他各组相比差异显著(P=0.000,0.000,0.003,0.001).浅表-萎缩-肠化-异型增生-胃癌,PGC表达与sPGA呈负相关,与sPGC呈正相关(r=0.956,P=0.011vssPGA;r=-0.968,P=0.007vssPGC).结论:PGC的动态表达与胃疾病的发生发展有良好的相关性;血清sPGA明显降低提示可能与胃癌的发生发展有关;若同时进行血清PG值及组织PGC抗原表达率检测,二者具有良好的相关性,可作为临床筛查胃癌及癌前疾病的指标. AIM:To detect the gastric expression levels of pepsinogen C (PGC) and serum levels of sPGA and sPGC in patients with various gastric diseases and to analyze their correlation.METHODS:Gastric PGC were measured by immunohistochemistry,and serum levels of sPGA,sPGC were measured by ELISA in patients with various gastric diseases,respectively.The data were analyzed for significance using the SPSS16.0 software.RESULTS:There were significant differences in gastric PGC expression among patients with different gastric diseases (P=0.000).The positive rate of PGC expression was highest in patients with superficial gastritis (SG),followed by those with atrophic gastritis (AG),intestinal metaplasia (IM),dysplasia (DYS) and gastric carcinoma (Ca).The positive rate of PGC was significantly higher in SG than in other lesions (P=0.035,0.000,0.000,0.000),in AG than in IM,DYS and Ca (P=0.000,0.000,0.031).There were also significant differences in serum levels of sPGA and sPGC among different patient groups (both P=0.000).Similar to PGC expression,serum levels of sPGA also decreased in an order of SG-AG-IM-DYSCa.In contrast,serum levels of sPGC in Ca were significantly higher than those in other lesions (P=0.000,0.000,0.003,0.001).The positive rate of PGC expression had a positive correlation with serum levels of sPGA and a negative correlation with serum levels of sPGC (r=0.956,P=0.011 vs sPGA;r=-0.968,P=0.007 vs sPGC).CONCLUSION:Tissue expression of PGC is negatively associated with the malignant degree of gastric mucosa cells and positively with the development of gastric mucosal diseases.Combined detection of sPG and PGC expression can help screen and diagnose gastric mucosal diseases.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第14期1242-1245,共4页 World Chinese Journal of Digestology
关键词 胃癌 胃蛋白酶原C 胃蛋白酶原A Gastric carcinoma Pepsinogen C Pepsinogen A
  • 相关文献

参考文献7

  • 1Kageyama T, Ichinose M, Tsukada-Kato S, Omata M, Narita Y, Moriyama A, Yonezawa S. Molecular cloning of neonate/infant-specific pepsinogens from rat stomach mucosa and their expressional change during development. Biochem Biophys Res Commun 2000; 267:806-812.
  • 2樊代明 张学庸 等.抗低分化胃癌细胞系MKN-46-9单克隆抗体的制备及免疫组化鉴定[J].解放军医学杂志,1988,13(1):12-12.
  • 3Korstanje A, den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnos- tic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand ] Gastroentervl Supp12002: 22-26.
  • 4李红梅,宁佩芳,袁媛.不同胃黏膜疾病胃蛋白酶原C组织原位表达与胃蛋白酶原血清学检测水平的比较[J].世界华人消化杂志,2005,13(20):2473-2476. 被引量:6
  • 5Fiocca R, Comaggia M, Villani L, Capella C, Solcia E, Samloff IM. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases. Cancer 1988; 61:956-962.
  • 6Fernandez R, Vizoso F, Rodriguez JC, Merino AM, Gonzalez LO, Quintela I, Andicoechea A, Truan N, Diez MC. Expression and prognostic significance of pepsinogen C in gastric carcinoma. Ann Surg Oncol 2000; 7:508-514.
  • 7谷敬丽.血清胃蛋白酶原、幽门螺旋杆菌与萎缩性胃炎相关性探讨[J].河南科技大学学报(医学版),2007,25(4):260-261. 被引量:6

二级参考文献22

  • 1袁媛,董明,何安光,张荫昌,张宝庚,金春莲,路平,邢承忠.正常人及胃癌患者胃蛋白酶原C基因多态性研究[J].中国医科大学学报,1995,24(3):233-235. 被引量:7
  • 2李月红,张祥宏,黄飚,王俊灵,米建民,申海涛,张志刚,严霞,邢凌霄,王士杰.胃癌高发区居民血清胃蛋白酶原水平及异常标准的研究[J].中华流行病学杂志,2006,27(10):840-844. 被引量:48
  • 3Lahner E, Caruana P, D'Ambra G, Ferraro G, Di Giulio E, Delle Fave G, Bordi C, Annibale B. First endoscopic-histologic followup in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc 2001; 53:443-448.
  • 4Conchillo JM, Houben G, de Bruine A, Stockbrugger R. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur J Cancer Prev 2001; 10:307-312.
  • 5Fernandez R, Vizoso F, Rodriguez JC, Merino AM, Gonzalez LO, Quintela I, Andicoechea A, Truan N, Diez MC. Expression and prognostic significance of pepsinogen C in gastric carcinoma. Ann Surg Oncol 2000; 7:508-514.
  • 6Kageyama T, Ichinose M, Tsukada-Kato S, Omata M, Narita Y, Moriyama A, Yonezawa S. Molecular cloning of neonate/infant-specific pepsinogens from rat stomach mucosa and their expressional change during development. Biochem Biophys Res Commun 2000; 267:806-812.
  • 7Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88:1239-1247.
  • 8Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT,Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50:378-381.
  • 9Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44:693-697.
  • 10Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003; 98:735-739.

共引文献26

同被引文献25

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部